Earnings Data
Report Date
Nov 05, 2026After Close (Confirmed)
Period Ending
2026 (Q3)Consensus EPS Forecast
-0.03Last Year’s EPS
-0.11Same Quarter Last Year
Strong Buy
Based on 4 Analysts Ratings
DE:BT3 Q2 2026 Earnings Report
DE:BT3 Upcoming Earnings
Lineage Therap's next earnings date is estimated for November 5, 2026, based on past reporting schedules.
DE:BT3 Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
DE:BT3 Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Aug 06, 2026 | €0.96 | €0.95 | -1.04% |
May 12, 2026 | €1.08 | €1.12 | +3.70% |
Mar 05, 2026 | €1.63 | €1.60 | -1.84% |
Nov 06, 2025 | €1.54 | €1.44 | -6.49% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Lineage Cell Therapeutics, Inc. (DE:BT3) report earnings?
Lineage Cell Therapeutics, Inc. (DE:BT3) is schdueled to report earning on Nov 05, 2026, After Close (Confirmed).
What is Lineage Cell Therapeutics, Inc. (DE:BT3) earnings time?
Lineage Cell Therapeutics, Inc. (DE:BT3) earnings time is at Nov 05, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Lineage Cell Therapeutics, Inc. stock?
The P/E ratio of Lineage Therap is N/A.
What is DE:BT3 EPS forecast?
DE:BT3 EPS forecast for the fiscal quarter 2026 (Q3) is -0.03.